269 related articles for article (PubMed ID: 35799474)
1. Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway.
Stålcrantz J; Kristoffersen AB; Bøås H; Veneti L; Seppälä E; Aasand N; Hungnes O; Kvåle R; Bragstad K; Buanes EA; Whittaker R
Scand J Public Health; 2022 Aug; 50(6):676-682. PubMed ID: 35799474
[TBL] [Abstract][Full Text] [Related]
2. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Biochemical Characteristics of COVID-19 Patients During the Delta-Omicron Wave with Risk Assessment of Adverse Outcomes.
Iqbal S; Khan S; Qureshi MA; Sayeed MA; Khan BA; Zaheer S; Faruqui H; Rajput AW
J Coll Physicians Surg Pak; 2023 Mar; 33(3):297-302. PubMed ID: 36945160
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
Butt AA; Dargham SR; Loka S; Shaik RM; Chemaitelly H; Tang P; Hasan MR; Coyle PV; Yassine HM; Al-Khatib HA; Smatti MK; Kaleeckal AH; Latif AN; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
Clin Infect Dis; 2022 Aug; 75(1):e361-e367. PubMed ID: 35404391
[TBL] [Abstract][Full Text] [Related]
6. Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases.
Harrigan SP; Wilton J; Chong M; Abdia Y; Velasquez Garcia H; Rose C; Taylor M; Mishra S; Sander B; Hoang L; Tyson J; Krajden M; Prystajecky N; Janjua NZ; Sbihi H
Clin Infect Dis; 2023 Feb; 76(3):e18-e25. PubMed ID: 36041009
[TBL] [Abstract][Full Text] [Related]
7. Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.
Veneti L; Bøås H; Bråthen Kristoffersen A; Stålcrantz J; Bragstad K; Hungnes O; Storm ML; Aasand N; Rø G; Starrfelt J; Seppälä E; Kvåle R; Vold L; Nygård K; Buanes EA; Whittaker R
Euro Surveill; 2022 Jan; 27(4):. PubMed ID: 35086614
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.
Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME
BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880
[TBL] [Abstract][Full Text] [Related]
9. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom.
Hyams C; Challen R; Marlow R; Nguyen J; Begier E; Southern J; King J; Morley A; Kinney J; Clout M; Oliver J; Gray S; Ellsbury G; Maskell N; Jodar L; Gessner B; McLaughlin J; Danon L; Finn A;
Lancet Reg Health Eur; 2023 Feb; 25():100556. PubMed ID: 36530491
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar.
Butt AA; Dargham SR; Tang P; Chemaitelly H; Hasan MR; Coyle PV; Kaleeckal AH; Latif AN; Loka S; Shaik RM; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
J Glob Health; 2022 Jul; 12():05032. PubMed ID: 35788085
[TBL] [Abstract][Full Text] [Related]
11. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients.
Hu FH; Jia YJ; Zhao DY; Fu XL; Zhang WQ; Tang W; Hu SQ; Wu H; Ge MW; Du W; Shen WQ; Zhu B; Chen HL
Clin Microbiol Infect; 2023 Jul; 29(7):835-844. PubMed ID: 36934872
[TBL] [Abstract][Full Text] [Related]
13. Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients.
Whittaker R; Bråthen Kristofferson A; Valcarcel Salamanca B; Seppälä E; Golestani K; Kvåle R; Watle SV; Buanes EA
Clin Microbiol Infect; 2022 Jun; 28(6):871-878. PubMed ID: 35219807
[TBL] [Abstract][Full Text] [Related]
14. Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study.
COVID-19 Omicron Delta study group
PLoS One; 2023; 18(4):e0282806. PubMed ID: 37104488
[TBL] [Abstract][Full Text] [Related]
15. Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022.
Piralla A; Mojoli F; Pellegrinelli L; Ceriotti F; Valzano A; Grasselli G; Gismondo MR; Micheli V; Castelli A; Farina C; Arosio M; Lorini FL; Fanti D; Busni A; Laratta M; Maggi F; Novazzi F; Cabrini L; Callegaro AP; Keim R; Remuzzi G; Cavallero A; Malandrin SMI; Rona R; Giardina F; Ferrari G; Zavaglio F; D'angelo P; Galli C; Bubba L; Binda S; Oggioni M; Uceda Renteria SC; Bono P; Baj A; Ferrante FD; Guarneri D; Tonelli M; Napolitano G; Nava A; Romeo L; Nicolini E; Valaperta R; Varisano L; Mele C; Liguori L; Raggi M; Mongodi S; Pagani M; Severgnini P; Gasberti D; Bonanomi E; Gritti P; Marrazzo F; Giovannini I; Sacchi N; Sagliocco O; Cereda D; Buoro S; Baldanti F; Pariani E
Respir Med Res; 2023 Jun; 83():100990. PubMed ID: 36871459
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Observational Study of Complete Blood Count (CBC) Parameters and ICU Mortality of COVID-19 Disease in Delta Variant and Omicron Variant in a Community-Based Hospital in New York City.
Yadav R; Yadav V; Pokhriyal S; Zahid U; Gandhi A
Cureus; 2023 Feb; 15(2):e34894. PubMed ID: 36925973
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y;
Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147
[TBL] [Abstract][Full Text] [Related]
18. Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.
Portmann L; de Kraker MEA; Fröhlich G; Thiabaud A; Roelens M; Schreiber PW; Troillet N; Iten A; Widmer A; Harbarth S; Sommerstein R;
JAMA Netw Open; 2023 Feb; 6(2):e2255599. PubMed ID: 36790812
[TBL] [Abstract][Full Text] [Related]
19. Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis.
Català M; Coma E; Alonso S; Andrés C; Blanco I; Antón A; Bordoy AE; Cardona PJ; Fina F; Martró E; Medina M; Mora N; Saludes V; Prats C; Prieto-Alhambra D; Alvarez-Lacalle E
Front Public Health; 2022; 10():961030. PubMed ID: 36033822
[TBL] [Abstract][Full Text] [Related]
20. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
